Home / Inspections / 1168524

FDA Inspection 1168524 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2473015

The FDA completed an inspection of New York Blood Center Enterprises on April 14, 2022 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 14, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rye, NY (United States)

Facility

Other inspections at this facility

  • 1283668 (VAI Wed Sep 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1217513 (NAI Thu Sep 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1209368 (VAI Thu Jul 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1118178 (VAI Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064704 (NAI Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources